Literature DB >> 27111241

Investing in People Who Inject Drugs: A PrEPonderance of Opportunities.

Rochelle P Walensky.   

Abstract

Entities:  

Year:  2016        PMID： 27111241     DOI： 10.7326/M16-0788

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

1.  Commentary: the value of PrEP for people who inject drugs.

Authors:  Rosalind L Coleman; Susie McLean
Journal:  J Int AIDS Soc       Date:  2016-10-18       Impact factor: 5.396

2.  M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID.

Authors:  Valérie Martel-Laferrière; Daniel J Feaster; Lisa R Metsch; Bruce R Shackman; Christine Loignon; Bohdan Nosyk; Hansel Tookes; Czarina N Behrends; Nelson Arruda; Oluleye Adigun; Marie-Eve Goyer; Michael A Kolber; Jean-Francois Mary; Allan E Rodriguez; Iveth G Yanez; Yue Pan; Rania Khemiri; Lauren Gooden; Aïssata Sako; Julie Bruneau
Journal:  Trials       Date:  2022-04-23       Impact factor: 2.728

3.  Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.

Authors:  Cora L Bernard; Douglas K Owens; Jeremy D Goldhaber-Fiebert; Margaret L Brandeau
Journal:  PLoS Med       Date:  2017-05-24       Impact factor: 11.613
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.